medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2021, Number 4

<< Back Next >>

Rev Latin Infect Pediatr 2021; 34 (4)

Cervical adenitis in pediatrics: 5 years of clinical and paraclinical characterization

Medina-Rivera S, Márquez-Herrera K, Ramírez-Iriarte KY, Ramos-Ramos C

Language: Spanish
References: 11
Page: 187-192
PDF size: 209.23 Kb.


ABSTRACT

Introduction: Cervical lymphadenopathy is a frequent manifestation in childhood and is a common reason for consultation. It is important to recognize those that are associated with a local infectious process, to determine the etiology and carry out an adequate antimicrobial treatment. Objective: To identify the clinical, microbiological and histopathological characteristics associated with cervical adenitis symptoms presented in patients aged 0-18 years, treated in a fourth level pediatric hospital. Material and methods: Cross-sectional analytical observational study. The medical records of patients aged 0-18 years with cervical adenitis, treated at the Fundación Hospital de la Misericordia in Bogotá, between January 1, 2013 and December 31, 2018 were reviewed. Results: 447 patients were included, 53.7% were male, with a median age of four years. Local pain, induration, and fever were found in 70, 61.7, and 56%, respectively. Serological tests were performed in 59 patients with seroprevalence of 67.7% for cytomegalovirus and 63.7% for Epstein Barr. 10% of the patients received surgical drainage; S. aureus was identified as the most frequent germ in 41% of the isolates, susceptible to oxacillin in 68.4%. 79.6% of the patients received antibiotic treatment, with cephalexin (35.8%) and clindamycin (24.6%) being the most used. Conclusions: There is a large underreporting of the clinical characteristics of adenitis and a wide use of antibiotics without indication. The causal agents coincide with those reported in the literature. The routine use of empirical antibiotics is discouraged, given the low frequency of progression to suppurative injury.


REFERENCES

  1. Gosche JR, Vick L. Acute, subacute, and chronic cervical lymphadenitis in children. Semin Pediatr Surg. 2006; 15 (2): 99-106.

  2. Niedzielska G, Kotowski M, Niedzielski A, Dybiec E, Wieczorek P. Cervical lymphadenopathy in children-Incidence and diagnostic management. Int J Pediatr Otorhinolaryngol. 2007; 71 (1): 51-56.

  3. Inman JC, Rowe M, Ghostine M, Fleck T. Pediatric neck abscesses-Changing organisms and empiric therapies. Laryngoscope. 2008; 118 (12): 2111-2114.

  4. Barton LL. Principles and practice of pediatric infectious diseases. JAMA. 2003; 289 (22): 3016-3017.

  5. Rajasekaran K, Krakovitz P. Enlarged neck lymph nodes in children. Pediatr Clin N am. 2013; 60: 923-936.

  6. Weinstock MS, Patel NA, Smith LP. Pediatric cervical lymphadenopathy. Pediatr Rev [Internet]. 2018; 39 (9): 433-443. Available in: http://pedsinreview.aappublications.org/content/39/9/433

  7. Kelly CS, Kelly J. Lymphadenopathy in children. Pediatr Clin North Am [Internet]. 1998; 45 (4): 875-888. Available in: http://www.ncbi.nlm.nih.gov/pubmed/9728192

  8. Nolder AR. Paediatric cervical lymphadenopathy: When to biopsy? Curr Opin Otolaryngol Head Neck Surg. 2013; 21 (6): 567-570.

  9. Leung AKC, Davies HD. Cervical lymphadenitis: etiology, diagnosis, and management. Curr Infect Dis Rep. 2009; 11 (3): 183-189.

  10. Leung AK, Robson WLM. Childhood cervical lymphadenopathy. J Pediatr Heal Care [Internet]. 2004; 18 (1): 3-7. Available in: http://linkinghub.elsevier.com/retrieve/pii/S0891524503002128

  11. Instituto Nacional De Salud. Boletín Epidemiológico. Una mirada hacia el comportamiento de la tuberculosis en Colombia, 2018 Semana epidemiológicas 1-36.




2020     |     www.medigraphic.com